The ANKZF1 Knockout HEK293T Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal cell population designed for loss-of-function studies of the ANKZF1 gene in a human embryonic kidney epithelial context. This heterogeneous pool results from targeted gene disruption at the ANKZF1 locus, enabling robust functional genomics analyses without clonal artifacts. Researchers can interrogate the effects of ANKZF1 inactivation across diverse genetic backgrounds, making it a critical tool for investigating transcriptional regulation and cell proliferation control in cancer biology.
HEK293T cells, the host line, are a well-established derivative of human embryonic kidney HEK293 cells that stably express the SV40 large T antigen. These adherent epithelial cells exhibit exceptionally high transfection efficiency and are widely utilized for recombinant protein expression, viral packaging, and functional assays. Their genetic tractability and rapid growth make them an ideal platform for CRISPR-mediated knockout models, providing a reliable cellular background for dissecting ANKZF1 function.
ANKZF1 encodes a protein containing ankyrin repeat and zinc finger domains, and is classified as a transcriptional regulator. Mechanistically, ANKZF1 functions downstream of growth factor signaling and cell cycle-dependent transcription factors, and forms complexes with transcriptional coregulators and chromatin remodeling factors to interact with the RNA polymerase II machinery. It transcriptionally regulates genes controlling cell cycle progression and apoptosis, positioning ANKZF1 as a key mediator of proliferation and survival. Disruption of ANKZF1 is therefore expected to impair these transcriptional programs, providing insights into its role in gastric and colorectal cancers.
In the HEK293T model, ANKZF1 knockout enables systematic dissection of its regulatory roles in an epithelial framework relevant to cancer. Despite their kidney origin, HEK293T cells recapitulate conserved signaling pathways perturbed in epithelial malignancies. The polyclonal knockout population captures a range of editing outcomes, offering a more naturalistic view of gene function than monoclonal lines. This model is thus valuable for assessing how ANKZF1 loss influences cell cycle dynamics, apoptosis sensitivity, and global transcriptional output.
Applications encompass functional genomics, cancer research, and drug target validation, with assays including western blotting, RT-qPCR, RNA-seq, proliferation and colony formation assays, flow cytometry, and immunofluorescence. These approaches enable detailed characterization of ANKZF1-dependent pathways and evaluation of therapeutic vulnerabilities. For further information and ordering details, please contact Ascent Research.
